Technical Analysis for LCTX - Lineage Cell Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 0.7429 3.54% 0.03
LCTX closed down 1.37 percent on Tuesday, November 12, 2019, on 1.66 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical LCTX trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 3.18%
Lower Bollinger Band Walk Weakness 3.18%
Earnings Movers Other 3.18%
Wide Bands Range Expansion 3.18%
Down 3 Days in a Row Weakness 3.18%
Down 4 Days in a Row Weakness 3.18%
Down 5 Days in a Row Weakness 3.18%
Lower Bollinger Band Touch Weakness 3.18%
Oversold Stochastic Weakness 3.18%
New 52 Week Closing Low Bearish 1.77%

Older signals for LCTX ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing therapies for the treatment of degenerative diseases in the United States and internationally. The company's lead product candidates include OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa multicenter trial for the treatment of the dry age-related macular degeneration; OPC1, an oligodendrocyte progenitor cell therapy that is in Phase I/IIa multicenter clinical trial for the treatment of acute spinal cord injuries; and VAC2, an allogeneic cancer immunotherapy of antigen-presenting dendritic cells, which is in Phase I clinical trial to treat non-small cell lung cancer. It also develops Renevia, a facial aesthetics product that is in pivotal clinical trial for the treatment of HIV-associated facial lipoatrophy; ReGlyde, a HyStem product in preclinical development as a device for viscosupplementation, and as a platform for intraarticular drug delivery in osteoarthritis; and Premvia, a Hystem Hydrogel product, as well as develop bone grafting products for the orthopedic diseases and injuries. In addition, it markets GeneCards, a human gene database; MalaCards, a human disease database; and Hextend, a plasma volume expander used to treat or prevent hypovolemia, including albumin, generic 6% hetastarch solutions, and crystalloid solutions, as well as undertakes various research programs for vision restoration and Demyelination. Lineage Cell Therapeutics, Inc. has a collaboration with Orbit Biomedical, Ltd. The company was formerly known as BioTime, Inc. and changed its name to Lineage Cell Therapeutics, Inc. in August 2019. Lineage Cell Therapeutics, Inc. was founded in 1990 and is headquartered in Carlsbad, California.
Biotechnology Life Sciences Biology Immunotherapy Stem Cells Non Small Cell Lung Cancer Osteoarthritis Drug Delivery Cell Therapy Stem Cell Therapy Degenerative Diseases Human Disease Injuries Biotime Dry Age Related Macular Degeneration
Is LCTX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 2.14
52 Week Low 0.66
Average Volume 376,632
200-Day Moving Average 1.1135
50-Day Moving Average 0.9301
20-Day Moving Average 0.8649
10-Day Moving Average 0.8005
Average True Range 0.0654
ADX 24.81
+DI 10.5516
-DI 33.2605
Chandelier Exit (Long, 3 ATRs ) 0.8238
Chandelier Exit (Short, 3 ATRs ) 0.8562
Upper Bollinger Band 1.0303
Lower Bollinger Band 0.6995
Percent B (%b) 0.06
BandWidth 38.247196
MACD Line -0.053
MACD Signal Line -0.042
MACD Histogram -0.0109
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.86
Resistance 3 (R3) 0.85 0.80 0.83
Resistance 2 (R2) 0.80 0.77 0.80 0.82
Resistance 1 (R1) 0.76 0.74 0.74 0.77 0.82
Pivot Point 0.71 0.71 0.70 0.71 0.71
Support 1 (S1) 0.67 0.68 0.65 0.68 0.62
Support 2 (S2) 0.62 0.65 0.62 0.62
Support 3 (S3) 0.58 0.62 0.61
Support 4 (S4) 0.59